Comparison of Intensive Versus Standard Care & Education for Dyslipidemia in Hypertension and Diabetes Patients
Recruiting · NCT07045623 · Interventional (participants receive a specific treatment) · Lead sponsor: Saint Vincent's Hospital, Korea
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The prevalence of dyslipidemia is high among patients with hypertension and diabetes mellitus, which increases the risk of cardiovascular disease. However, many patients lack awareness and adherence to treatment and lifestyle modifications. Therefore, a more structured and intensive approach to management and education is required. This study aims to implement intensive dyslipidemia management and education for patients registered at the Hanam City Hypertension and Diabetes Education Center and evaluate changes in blood lipid levels accordingly. Additionally, the study will analyze the impact of intensive education on patients' quality of life, health behaviors, and treatment adherence, ultimately contributing to the development of effective management strategies.
Who can take part
Inclusion criteria
- Patients registered in the Hanam City Hypertension and Diabetes Program
- Adults aged 30 to 80 years
- Individuals who have provided written informed consent to participate in the study
Exclusion criteria
- Chronic kidney disease stage 4 or higher (eGFR \<30 mL/min/1.73m²)
- Patients with liver cirrhosis or severe liver disease
- Patients with a history of acute coronary syndrome within the past 6 months
- Pregnant or breastfeeding women • Individuals with psychiatric disorders that may affect study participation
Where it is running
1 location listed.
- Catholic University of Korea, ST. Vincent's Hospital. - Gyeonggi-do, Suwon-si, South Korea